mTORキナーゼの構造,メカニズム,および調節について
Haijuan Yang1, Derek G Rudge, Joseph D Koos
1Structural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Nature
|May 3, 2013
まとめ
ラパミシン (mTOR) キナーゼ構造の哺乳類の標的は,本質的に活性な構成を明らかにします. その活動は,FRBドメインと阻害ヘリックスによって制御される,制限されたアクティブサイトアクセスによって規制されます.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 構造生物学 構造生物学とは
背景:
- 哺乳類の標的であるラパミシン (mTOR) は,細胞成長の重要な調節因子であり,がんでは頻繁に調節が失われます.
- mTORの構造と調節を理解することは,標的がん治療の開発に不可欠です.
研究 の 目的:
- 断片化されたmTOR-mLST8複合体の共結晶構造を解明する.
- mTORの活性化と抑制の構造的基礎を調査する.
主な方法:
- mTOR-mLST8複合体の同結晶構造の決定とATP移行状態の模倣と阻害剤.
- 基質へのアクセスと阻害メカニズムを研究するためのインビトロ生化学分析.
主要な成果:
- mTORキナーゼは,内在的に活性な形状を示し,活性部位が収縮している.
- FKBP12-ラパミシン・バインディング (FRB) ドメインはゲートキーパーとして作用し,基板へのアクセスを規制します.
- ラパミシン-FKBP12は,基板の採用を阻止し,アクティブサイトへのアクセスを制限することによってmTORを阻害します.
- mTORを活性化する変異は,アクティブサイトへのアクセスを制御する構造的枠組みに影響します.
結論:
- mTORのキナーゼ活動は,その活性部位へのアクセス制限によって厳しく規制されています.
- FRBドメインは,基板認識とmTOR規制において重要な役割を果たします.
- 構造的洞察は,mTOR阻害剤の効能と特異性を理解するための基礎を提供します.
関連する概念動画
Protein Kinases and Phosphatases
15.6K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.6K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K
Receptor Tyrosine Kinases
20.9K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
20.9K
MAPK Signaling Cascades
9.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K
PI3K/mTOR/AKT Signaling Pathway
6.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.4K
mTOR Signaling and Cancer Progression
1.7K
No description available
1.7K


